Procter & Gamble Health (PGHL.NS) Stock Price
Procter & Gamble Health Price
Revenue has compounded at 7.9% per year over the past 19 years to 14.08 B INR. Earnings per share have grown at 4.8% per year over the last 19 years. Procter & Gamble Health's net margin stands at 23.2%, up from 17.3% several years earlier. Procter & Gamble Health currently offers a dividend yield of about 2.32%. The payout ratio is around 63% of earnings. The dividend has grown at 10.7% per year over the past 18 years. Analysts set a median price target of 5,339.70 INR, implying 0.8% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Procter & Gamble Health stock price
Procter & Gamble Health business model & stock analysis
Frequently asked questions about Procter & Gamble Health
The business model of Procter & Gamble Health Ltd revolves around manufacturing and selling a wide range of consumer healthcare products. As a subsidiary of Procter & Gamble Company, it focuses on developing and marketing products that help consumers improve their health and well-being. Procter & Gamble Health Ltd aims to offer innovative pharmaceuticals, over-the-counter medications, and personal care products to meet the needs of its customers. By consistently delivering high-quality and reliable products, the company strives to maintain a strong market presence and generate sustainable revenue growth.
Procter & Gamble Health Ltd is primarily active in the healthcare industry.
The main competitors of Procter & Gamble Health Ltd in the market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, and Sanofi.
Procter & Gamble Health Ltd, previously known as Merck Limited, is a leading healthcare company in India. The company has a rich history that dates back to 1967 when it was incorporated as a joint venture between Merck & Co. Inc. (USA) and a local promoter group. Over the years, it has established itself as a trusted name in the pharmaceutical industry, providing a wide range of innovative healthcare solutions. Procter & Gamble Health Ltd focuses on delivering high-quality products in areas such as vitamins, cough drops, and over-the-counter medicines. With its commitment to improving the well-being of consumers, the company continues to play a vital role in shaping the healthcare landscape in India.
Procter & Gamble Health Ltd has achieved various significant milestones throughout its history. With a rich legacy spanning decades, the company has successfully established itself as a leader in the healthcare industry. It has consistently delivered innovative and high-quality healthcare solutions, contributing to improved well-being and quality of life for consumers worldwide. Procter & Gamble Health Ltd has continually expanded its product portfolio, ranging from over-the-counter medications and nutritional supplements to personal care products. Additionally, the company has achieved noteworthy financial growth, expanding its market reach and generating substantial value for its shareholders. Procter & Gamble Health Ltd's commitment to excellence and continuous innovation has solidified its position as a trusted and respected name in the healthcare sector.
Procter & Gamble Health Ltd is primarily present in India.
Procter & Gamble Health Ltd represents strong values and a corporate philosophy centered around improving lives through innovative healthcare solutions. With a commitment to delivering quality health and wellness products, the company strives to enhance the well-being of individuals and families worldwide. Procter & Gamble Health Ltd emphasizes integrity, excellence, and collaboration in all aspects of its operations. By continuously investing in research and development, the company aims to provide trusted and effective healthcare solutions to meet the diverse needs of consumers. With its customer-centric approach and dedication to advancing healthcare, Procter & Gamble Health Ltd is a leading player in the industry.
Analysts currently set an average price target of 5,339.70 INR for the Procter & Gamble Health stock (median: 5,339.70 INR), implying -0.8 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Procter & Gamble Health stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Procter & Gamble Health to generate revenue of 13.52 B INR and earnings per share of 189.89 INR.
Converted at the current exchange rate, the Procter & Gamble Health share trades at 49.75 EUR (5,383.50 INR).
The Procter & Gamble Health share (PGHL.NS) is listed on 2 stock exchanges, including: NSE (Indien) (PGHL.NS).
Procter & Gamble Health Ltd is a leading company in the health and personal care industry, offering a wide range of innovative products and solutions. The company offers products in various categories, including baby care, skincare, oral care, and women’s health. Its baby care products include diapers, wet wipes, baby soap, and baby oil. The skincare products include a wide range of items such as moisturizers, body lotions, and cleansers. The oral care products include toothpaste, mouthwash, and dental floss. The women’s health products include feminine hygiene products such as sanitary pads, tampons, and panty liners. Procter & Gamble Health Ltd strives to develop its products based on innovation, quality, and safety. The company invests in research and development to ensure that its products meet the highest quality standards. It also engages in clinical studies to verify the effectiveness and safety of its products. In addition to selling retail products, Procter & Gamble Health Ltd also operates an extensive business in the medical professionals’ sector. The company conducts educational programs for doctors and medical practitioners to improve their understanding of the products and their application. It also collaborates with leading medical institutions to advance research and innovation in the healthcare industry. Procter & Gamble Health Ltd has a strong global presence and operates in more than 180 countries. The company has a strong market position in the major markets of Europe, Americas, Asia, and the Middle East. It also works with leading distribution partners in all regions to ensure that its products are available worldwide. Overall, Procter & Gamble Health Ltd has a successful business model based on the development and provision of innovative health and personal care products. The company is committed to quality and safety and engages in research and development as well as medical education programs to strengthen its position in the industry. With a large global presence and a diverse product portfolio, Procter & Gamble Health Ltd is well-positioned to continue its successful growth and meet the needs of its customers worldwide.
The expected revenue of Procter & Gamble Health is 13.52 B INR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Procter & Gamble Health is 3.15 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Procter & Gamble Health is currently 28.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Procter & Gamble Health stock.
The price-to-sales ratio (P/S) of Procter & Gamble Health is currently 6.61. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Procter & Gamble Health stock.
The Eulerpool Quality Score for Procter & Gamble Health is 5/10.
The ISIN of Procter & Gamble Health is INE199A01012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Procter & Gamble Health is PGHL.NS. The ticker symbol is used to trade Procter & Gamble Health shares on the stock exchange.
Procter & Gamble Health stock
Procter & Gamble Health Peer Group
Procter & Gamble Health Ticker
Procter & Gamble Health FIGI
All fundamentals and in-depth analysis of Procter & Gamble Health
Our stock analysis for Procter & Gamble Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procter & Gamble Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.